NASDAQ · MEDICINAL CHEMICALS & BOTANICAL PRODUCTS · MID CAP
Canopy Growth Corporation CGC
9 fiscal years on record · CAD · FY2025 reported
SEC FILINGS ONLY
Revenue · FY2025
CAD 284.6M
▲ 5.8% vs FY2024
EPS · FY25
CAD -0.88
Dividend / sh · FY25
—
Payout · FY25
—
ROE · FY25
-44.7%
Net margin · FY25
-92.4%
Dividend coverage
—
Advertisement
AdSense · Leaderboard 728×90320×100
Result
CAD 284.6M
Revenue, FY2025 · full 9-year series below
Revenue
Net income
The company lost 92 cents on every revenue dollar this year.
Per share
CAD -0.88
Diluted EPS, FY2025
EPS
The company pays no cash dividend.
Profitability
-44.7%
Return on equity, FY2025
ROE
Operating margin-56.8%
Net margin-92.4%
Return on assets-25.8%
Each CAD of equity lost 45 cents this year.
Returned to shareholders
—
returned in FY2025 · dividends + net buybacks
Dividends paid—
Net buybacks—
Share of profit—
Consecutive raises—
Growth
−12.2% a year
revenue, compounded over five years
CAGR
3 yrs
5 yrs
10 yrs
15 yrs
Revenue
−5.1%
−12.2%
Compound annual rates per period — left blank where the series crosses a loss.
Share base
0.42B
Shares outstanding, FY2025
Change, 5 years—
Change, 10 years—
A share split breaks the comparison across the period, so we leave it out.
Advertisement
AdSense · Leaderboard 728×90300×250
Balance sheet
CAD 1.1B
total assets, end of FY2025
Total assetsCAD 1.1B
EquityCAD 697.6M
CashCAD 364.7M
Gross debtCAD 233.4M
Net debtCAD -131.3M
Current ratio3.34×
The company holds more cash than debt.
History
9 fiscal years
Every figure from documents filed with the SEC · CAD
Metric
2025
2024
2023
2022
2021
2020
2019
2018
2017
Revenue CAD B
0.3
0.3
0.3
0.3
0.5
0.5
0.4
0.2
0.1
Operating income CAD B
−0.2
−0.1
−0.2
−2.6
−1.0
−1.2
−1.7
−0.6
−0.1
EBITDA CAD B
−0.1
−0.1
−0.2
−2.6
−0.9
−1.2
−1.6
−0.6
−0.1
Income tax CAD B
0.0
0.0
0.0
−0.0
−0.0
−0.0
−0.1
0.0
−0.0
Net income CAD B
−0.3
−0.5
−0.7
−3.3
−0.3
−1.7
−1.3
−0.7
−0.1
EPS, diluted CAD
−0.88
−4.73
−9.27
−70.69
−7.92
−4.69
−3.80
−2.76
−0.38
Dividend / sh CAD
·
·
·
·
·
·
·
·
·
Payout %
·
·
·
·
·
·
·
·
·
ROE %
−44.7
−115.8
−119.7
−151.0
−8.8
−41.7
−22.7
−10.9
·
Shares out B
0.42
0.18
0.09
0.05
·
·
·
·
·
Slide the table for earlier years · "·" marks figures not disclosed in the filing for that year.
How we verifyAUDITED
34 of 34
checks passed before publication
EPS recomputationBalance-sheet identityGross profitBalance-sheet liquidity
Every figure was compared against the original statement: 0 failures and 0 presentation gaps.
What we don’t show
We’d rather say what’s missing than fill the gap with an estimate.
P/E rationeeds a market quote — not yet licensed
Market capitalizationneeds a market quote — not yet licensed
Dividend yieldneeds a market quote — not yet licensed
Price-to-bookneeds a market quote — not yet licensed